Dr. Nandini Tandon, Ph.D., an entrepreneur and venture capitalist in Silicon Valley, invests in cutting edge innovation sustainable for business and society, in life sciences and Healthcare/IT in USA, India and emerging markets.
Dr. Tandon is Vice Chairman, Board Member, for El Camino Hospital, Silicon Valley, California. Prior to that, she was Managing Director, Lumira/MDS Capital in Palo Alto with $1.2 Billion under management and before was Partner, RBC Capital Partners, in San Francisco.
Nandini is very engaged in building partnership between USA and India. She co-chaired Healthcare delegation of Mayor of San Francisco to India, under SF-Bangalore Sister City initiative. The delegation successfully launched discussions between Bay area hopsitals and clinics and Indian counterparts to collaborate on areas of mutual interest and best practices.
Nandini was invited by President Obama’s US State Department’s Global Entrepreneurship program to Turkey and Dubai, focusing on innovation in healthcare; she moderated three USA Senator’s congressional delegation to India focusing on building partnerships between USA and India in healthcare, Chaired, ”20/20”Vision: Investing in USA & Emerging Markets” held at Stanford University. She is on the Advisory Board for MD Anderson Cancer Center for
PD & Entrepreneurship; Board of Trustees, Bay Area Council Economic Institute; Advisory Council, Stanford School of Medicine Career Center; Board Member, Univ. of California, Berkeley, Center for Emerging and Neglected Diseases; Board Member, C21 BioVentures. She spoke at the former Secretary of the Treasury Geithner’s US Department of Treasury symposium on Women in Finance, and is former Board of Trustee for TiE Global.
Nandini has an exceptional track record as a venture capitalist with 12 investments in innovative break through technology companies (in oncology, cardiology, pediatrics, cognitive impairment etc.) with 8 being acquired within few years of investment by market leaders such as Pfizer, General Electric, Gilead, Amgen, Biogen-IDEC, Cephalon, CSI and Millipore respectively, and 2 companies following IPO route.
Nandini has been on the Board of 12 plus high-tech for profit companies supporting development of products for unmet medical needs. She was most recently Board Member for U-Systems Inc. in Silicon Valley, which got acquired by General Electric for its history making breast cancer early detection technology leading to saving precious lives, and especially suited to Indian/Asian women given their tissue type. She was invited by Harvard Business School’s women conference to give a talk on women leadership in board governance.
A White House Intern, Nandini received Ph.D. in biochemistry, Phi Lambda Upsilon from Duke University, and her B.A. cum laude and Phi Beta Kappa from Hollins University, USA.
Dr.Tandon is co-chair of SF-Bangalore Sister City initiative’s SF-India focus to catalyze collaborations between San Francisco/Bay area and India.